Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
RHOA
REST API REST API
Homo sapiens
RHOA is differentially expressed in 266 experiments: 118 organism parts: bone marrow, placenta, ... (116 more);, 162 disease states: normal, chronic myelogenous leukemia, ... (160 more);, 86 cell types 336 cell lines 25 compound treatments and 72 other conditions.
Synonyms RhoA, ARHA, ARH12, Rho12, RHOH12
Orthologs F1NLM4_CHICK (Gallus gallus)   RSA-14-44 (Rattus norvegicus)   RHOA_BOVIN (Bos taurus)   RHO1 (Saccharomyces cerevisiae)   Rhoa (Mus musculus)   Q7YT82_CIOIN (Ciona intestinalis)   Rho1 (Drosophila melanogaster)   rhoab (Danio rerio)   rhoa (Xenopus laevis)   RHOA_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, plasma membrane, GTPase activity, protein binding, cleavage furrow, regulation of axonogenesis, cytoskeleton, cytoplasm, intracellular, cell cortex, membrane, blood coagulation, cell morphogenesis, Rho protein signal transduction, cell differentiation, GTP catabolic process, GTP binding, cell adhesion, actin cytoskeleton organization, axon guidance, small GTPase mediated signal transduction, myosin binding, cell-matrix adhesion, nucleus, regulation of cell migration, regulation of small GTPase mediated signal transduction, nucleotide binding, regulation of transcription from RNA polymerase II promoter, skeletal muscle tissue development, signal transduction, protein transport, mitochondrion, negative regulation of neuron apoptosis, positive regulation of axonogenesis, positive regulation of I-kappaB kinase/NF-kappaB cascade, androgen receptor signaling pathway, positive regulation of NF-kappaB import into nucleus, positive regulation of neuron differentiation, positive regulation of stress fiber assembly, stress fiber assembly, interspecies interaction between organisms, negative regulation of axonogenesis, nerve growth factor receptor signaling pathway, spindle assembly involved in mitosis, negative regulation of steroid hormone receptor signaling pathway, platelet activation, ruffle membrane, phosphatidylinositol-mediated signaling, positive regulation of cell cycle cytokinesis
InterPro Term MIRO-like, ProtSyn_GTP-bd, Small_GTPase, Small_GTP-bd_dom, Small_GTPase_ARF/SAR, Small_GTPase_Ras, Small_GTPase_Rho, Small_GTPase_Rab_type
UniProt Accession C9J1T2, P61586, C9JNR4, C9JRM1, C9JX21, Q9BVT0, B4DKN9
Search EB-eye ENSG00000067560
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-6573, E-GEOD-1577, E-GEOD-3526, ... (28 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, E-GEOD-19397, ... (39 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-5823, E-GEOD-19639, E-GEOD-20081
HL-60
2
E-GEOD-5258, E-MTAB-37
HCC38
2
E-MTAB-37, E-MTAB-62
Daudi
2
E-MTAB-37, E-GEOD-96
HepG2
2
E-GEOD-21154, E-GEOD-7307
GM19099
1
E-GEOD-19466
330 more value(s).


Cell type

studied in E-GEOD-16058, E-GEOD-22373, E-GEOD-21668, E-GEOD-19397, E-GEOD-3920, ... (44 experiments)

Factor Value U/D Experiments
fibroblast
2
E-GEOD-26672, E-GEOD-3920
n/a
1
E-MTAB-24
mononuclear cell
1
E-GEOD-6053
bronchial epithelial
1
E-AFMX-5
granulopoietic
1
E-GEOD-9894
CD34+
1
E-AFMX-5
80 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-1577, E-TABM-15, ... (54 experiments)

Factor Value U/D Experiments
astrocytoma
2
E-MTAB-37, E-GEOD-4290
acute promyelocytic leukemia
2
E-MTAB-62, E-GEOD-995
colon carcinoma
2
E-MTAB-62, E-GEOD-3726
obesity
2
E-MTAB-62, E-GEOD-2508
control
1
2
E-GEOD-21912, E-GEOD-16728, E-GEOD-8121
lung adenocarcinoma
1
2
E-MTAB-37, E-GEOD-2514, E-MEXP-231
156 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-6907, E-TABM-782, E-GEOD-5824, E-GEOD-15811, ... (16 experiments)

Factor Value U/D Experiments
none
1
7
E-GEOD-5824, E-GEOD-2803, E-GEOD-412, E-GEOD-2649, E-TABM-782, ... (8 experiments)
arsenic oxide
1
E-GEOD-6907
estradiol
1
E-GEOD-20081
unknown
1
E-GEOD-7307
bis [(+)-tartrato] diantimonate (III) dipotassium trihydrate
1
E-GEOD-6907
nickel(II) chloride hexahydrate
1
E-GEOD-6907
19 more value(s).


A rna yield

studied in E-TABM-325

Factor Value U/D Experiments
74.51
1
1
E-TABM-325


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-TABM-325, E-MTAB-37, E-GEOD-14359

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-21374, ... (10 experiments)

Clinical treatment
studied in E-GEOD-6532

Construct
studied in E-GEOD-22369, E-GEOD-22366

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-16058, E-GEOD-20033, E-GEOD-6236, E-GEOD-2666, E-MTAB-62 ... (5 experiments)

Dfs follow up
studied in E-GEOD-22541

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-GEOD-22148, E-TABM-147, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, E-GEOD-6431

Genotype
studied in E-GEOD-1923, E-TABM-1029, E-GEOD-22056, E-GEOD-2466, E-GEOD-17476, ... (12 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-TABM-127, E-GEOD-20540, E-MEXP-1446, ... (8 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-2466, E-MEXP-2069, E-GEOD-1926, ... (33 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-980, ... (6 experiments)

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977

Labeling
studied in E-LGCL-5

Library source
studied in E-GEOD-19323

Light
studied in E-GEOD-1725

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Phenotype
studied in E-GEOD-22309, E-GEOD-17636

Progesterone receptor status
studied in E-GEOD-3494

Protocol type
studied in E-GEOD-3254, E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-TABM-585, E-GEOD-18791

Rna integrity
studied in E-TABM-325

RNAi
studied in E-GEOD-1676, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, E-MEXP-2759 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

Sex
studied in E-GEOD-2508, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-1561, E-GEOD-4922

Processing time: 0.331 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM